Your browser doesn't support javascript.
loading
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.
Batlle-López, Ana; González de Villambrosía, Sonia; Francisco, Mazorra; Malatxeberria, Sefora; Sáez, Anabel; Montalban, Carlos; Sánchez, Lydia; Garcia, Juan; González-Barca, Eva; López-Hernández, Andrés; Ruiz-Marcellan, M C; Mollejo, Manuela; Grande, Carlos; Richards, Kristy L; Hsi, Eric D; Tzankov, Alexandar; Visco, Carlo; Xu-Monette, Zijun Y; Cao, Xin; Young, Ken H; Piris, Miguel Ángel; Conde, Eulogio; Montes-Moreno, Santiago.
Afiliação
  • Batlle-López A; Departments of Haematology and Pathology, Hospital Marques de Valdecilla, and IDIVAL, Santander, Spain.
  • González de Villambrosía S; Departments of Haematology and Pathology, Hospital Marques de Valdecilla, and IDIVAL, Santander, Spain.
  • Francisco M; Departments of Haematology and Pathology, Hospital Marques de Valdecilla, and IDIVAL, Santander, Spain.
  • Malatxeberria S; Departments of Haematology and Pathology, Hospital Marques de Valdecilla, and IDIVAL, Santander, Spain.
  • Sáez A; Biobanco del Sistema Sanitario Público de Andalucía, Granada, Spain.
  • Montalban C; MD Anderson Cancer Center, Madrid, Spain.
  • Sánchez L; Biotechnology Programme, Histology and Immunohistochemistry Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Garcia J; Pathology, MD Anderson Cancer Center, Madrid, Spain.
  • González-Barca E; Department of Haematology, Hospital de Bellvitge (ICOIRO), Barcelona, Spain.
  • López-Hernández A; Departments of Pathology and Haematology, Hospital Vall d'Hebron, Barcelona, Spain.
  • Ruiz-Marcellan MC; Departments of Pathology and Haematology, Hospital Vall d'Hebron, Barcelona, Spain.
  • Mollejo M; Hospital Virgen de la Salud, Toledo, Spain.
  • Grande C; Hematology, Hospital 12 de Octubre, Madrid, Spain.
  • Richards KL; Department of Hematology-Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Hsi ED; Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA.
  • Tzankov A; University Hospital, Basel, Switzerland.
  • Visco C; Department of Hematology, San Bortolo Hospital, Vicenza, Italy.
  • Xu-Monette ZY; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cao X; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Young KH; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Piris MÁ; Departments of Haematology and Pathology, Hospital Marques de Valdecilla, and IDIVAL, Santander, Spain.
  • Conde E; Departments of Haematology and Pathology, Hospital Marques de Valdecilla, and IDIVAL, Santander, Spain.
  • Montes-Moreno S; Departments of Haematology and Pathology, Hospital Marques de Valdecilla, and IDIVAL, Santander, Spain.
Oncotarget ; 7(14): 18036-49, 2016 Apr 05.
Article em En | MEDLINE | ID: mdl-26910115
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article